MolNFT v1 · #81671 · protein
Crystal structure of monobody SH13/ABL1 SH2 domain complex
3UYO · Tyrosine-protein kinase ABL1: “Crystal structure of monobody SH13/ABL1 SH2 domain complex”. X-ray diffraction, 1 ligand (SO4), 2 pockets (best druggability 0.54). MolNFT v1 #81671 on GenesisL1: 3D structure, binding sites and…
- PDB
- 3UYO
- Type
- protein
- Length
- 208 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tyrosine-protein kinase ABL1; Monobody SH13
- EC
- 2.7.10.2
- UniProt
- P00519
- Ligands
- SO4
- Pockets
- 2 · best druggability 0.54
Structure
x-ray diffraction · 2 distinct chains · 9% helix, 37% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tyrosine-protein kinase ABL1 (EC 2.7.10.2) | protein | 114 | 17% helix, 30% strand | P00519 |
| D | Monobody SH13 | protein | 94 | 0% helix, 46% strand | — |
Ligands and binding sites
- SO4 · Sulfate ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 238 | 0.54 | 0.77 | 34 | empty |
| 2 | 116 | 0.41 | 0.76 | 19 | empty |
Interfaces
1 interface between chains.
- A–D · 929 Ų buried · 13 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00519
- Elsewhere: RCSB PDB 3UYO · PDBe 3UYO · UniProt P00519
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.